FARALLON CAPITAL MANAGEMENT, L.L.C.
Institutional investor · Portfolio as of Q2 2026
Top Holdings89 positions
STATE STR SPDR S&P 500 ETF T | 6M | $4.5B | 20.7% | — | — | — | New — |
REVOLUTION MEDICINES INC | 13.6M | $2.5B | 11.7% | $35.04 | +440.15% | 22 qtrssince 2021-Q1 | Decreased 0 |
ELECTRONIC ARTS INC | 7.9M | $1.6B | 7.5% | $203.43 | +3.08% | 3 qtrssince 2025-Q4 | Increased 66 |
BRIDGEBIO PHARMA INC | 10.7M | $800.1M | 3.7% | $43.29 | +55.05% | 8 qtrssince 2024-Q3 | Increased 67 |
PROTAGONIST THERAPEUTICS INC | 6.3M | $778.2M | 3.6% | $22.07 | +518.66% | 31 qtrssince 2018-Q4 | Unchanged 0 |
EXELIXIS INC | 13.5M | $732.8M | 3.4% | $24.12 | +160.48% | 31 qtrssince 2018-Q4 | Increased 60 |
LIQUIDIA CORPORATION | 8.4M | $666.9M | 3.1% | $18.21 | +91.03% | 10 qtrssince 2024-Q1 | Decreased 0 |
AMAZON COM INC | 2.6M | $627.5M | 2.9% | $225.22 | +13.12% | 5 qtrssince 2025-Q2 | Decreased 0 |
LANTHEUS HLDGS INC | 5.6M | $619.4M | 2.9% | $78.29 | +27.71% | 14 qtrssince 2023-Q1 | Unchanged 0 |
NATERA INC | 2.2M | $602.2M | 2.8% | $74.59 | +442.68% | 21 qtrssince 2021-Q2 | Decreased 0 |
UNITEDHEALTH GROUP INC | 1.3M | $528.1M | 2.4% | $412.83 | -1.49% | 14 qtrssince 2023-Q1 | Decreased 0 |
THERMO FISHER SCIENTIFIC INC | 1M | $526M | 2.4% | $468.64 | +48.62% | 27 qtrssince 2019-Q4 | Increased 63 |
ROIVANT SCIENCES LTD | 14.3M | $506.4M | 2.3% | $30.25 | +12.54% | 13 qtrssince 2023-Q2 | Increased 74 |
AON PLC | 1.4M | $458.6M | 2.1% | $329.96 | -13.08% | 10 qtrssince 2024-Q1 | Decreased 0 |
BOSTON SCIENTIFIC CORP | 10.5M | $449M | 2.1% | $64.74 | -31.82% | 24 qtrssince 2020-Q3 | Increased 71 |
BROADCOM INC | 1.2M | $435.1M | 2.0% | $326.98 | +5.31% | 3 qtrssince 2025-Q4 | Decreased 0 |
MICROSOFT CORP | 1.1M | $415.1M | 1.9% | $340.17 | +58.58% | 31 qtrssince 2018-Q4 | Decreased 0 |
TANGO THERAPEUTICS INC | 12.3M | $383.8M | 1.8% | $12.04 | +88.59% | 7 qtrssince 2024-Q4 | Increased 63 |
KKR & CO INC | 4.1M | $378M | 1.7% | $107.09 | -18.17% | 3 qtrssince 2025-Q4 | Decreased 0 |
SYNOPSYS INC | 829,600 | $370.1M | 1.7% | $456.80 | +2.48% | 3 qtrssince 2025-Q4 | Decreased 0 |
FARALLON CAPITAL MANAGEMENT, L.L.C. manages $21.7B across 89 positions as of Q2 2026. Top holdings: SPY puts (20.7%), RVMD (11.7%), EA (7.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.
Active quarter - 20 new positions, 104 exits, 29 increased. Top move: ROIV (INCREASED, conviction 74). Portfolio: $21.7B across 89 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR